Voyager Therapeutics, Inc. Expense Breakdown
No Expense Breakdown for VYGR on this site yet.
- 2026-06-30: Single Reportable $7.52M.
- 2025-06-30: Single Reportable $10.49M.
Source checked: the stored Expense Breakdown page for VYGR.
Expenses by product
General and Administrative Expense: each quarter (3 month)
| Quarter end | Single Reportable |
|---|---|
| 2026-06-30 | $7.52M |
| 2025-06-30 | $10.49M |
Income Tax Expense (Benefit): each quarter (3 month)
| Quarter end | Single Reportable |
|---|---|
| 2026-06-30 | $20.00K |
| 2025-06-30 | $15.00K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |